These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18581891

  • 1. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 2. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun 20; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 4. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J, Niemczyk S, Przedlacki J, Puka J, Switalski M, Ostrowski K.
    Pol Arch Med Wewn; 2004 Jul 20; 112(1):797-803. PubMed ID: 15526839
    [Abstract] [Full Text] [Related]

  • 5. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z, Karadag-Saygi E, Unlu-Ozkan F, Akyuz G.
    Aging Male; 2007 Dec 20; 10(4):197-201. PubMed ID: 18033629
    [Abstract] [Full Text] [Related]

  • 6. Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.
    Liu P, Yang DQ, Xie F, Zhou B, Liu M.
    Genet Mol Res; 2014 Jul 24; 13(3):5285-91. PubMed ID: 25078584
    [Abstract] [Full Text] [Related]

  • 7. Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.
    Hejdova M, Palicka V, Kucera Z, Vlcek J.
    Pharm World Sci; 2005 Jun 24; 27(3):149-53. PubMed ID: 16096879
    [Abstract] [Full Text] [Related]

  • 8. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L, Kettenbach J, Kiener H, Graninger W, Kainberger F, Pietschmann P.
    Wien Klin Wochenschr; 1997 Apr 25; 109(8):270-4. PubMed ID: 9163888
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 25; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 10. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H, Sipahioğlu S, Aksoy N, Baykara İ, Işıkan UE.
    Acta Orthop Traumatol Turc; 2015 Feb 25; 49(2):160-5. PubMed ID: 26012937
    [Abstract] [Full Text] [Related]

  • 11. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr 25; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun 25; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 13. Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
    Wei Y, Kong XL, Li WB, Wang ZS.
    Ther Apher Dial; 2014 Dec 25; 18(6):618-22. PubMed ID: 24674384
    [Abstract] [Full Text] [Related]

  • 14. Effects of Teriparatide versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials.
    Chen C, Alqwbani M, Zhao J, Yang R, Wang S, Pan X.
    Endocr Metab Immune Disord Drug Targets; 2021 Dec 25; 21(5):932-942. PubMed ID: 33109070
    [Abstract] [Full Text] [Related]

  • 15. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z.
    Eur J Med Res; 2018 Apr 17; 23(1):18. PubMed ID: 29665846
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP, Lyritis GP, Galanos A, Raptou P, Constantelou E.
    J Bone Miner Res; 2002 Mar 17; 17(3):521-7. PubMed ID: 11874243
    [Abstract] [Full Text] [Related]

  • 17. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E, Csupor E, Mészáros S, Ferencz V, Németh L, McCloskey EV, Horváth C.
    Bone; 2005 Jan 17; 36(1):47-51. PubMed ID: 15664001
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M.
    Osteoporos Int; 1999 Jan 17; 10(2):128-36. PubMed ID: 10501793
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.
    Huang GS, Chu TS, Lou MF, Hwang SL, Yang RS.
    BMC Musculoskelet Disord; 2009 Jun 04; 10():60. PubMed ID: 19497099
    [Abstract] [Full Text] [Related]

  • 20. Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients.
    Wu Q, Xiao DM, Fan WF, Ye XW, Niu JY, Gu Y.
    Ther Apher Dial; 2014 Oct 04; 18(5):427-33. PubMed ID: 25196492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.